Cargando…
Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context
After the first confirmed case in 2019, COVID-19 rapidly spread worldwide and overwhelmed the medical community. In the intervening time, we have learned about COVID-19’s clinical manifestations and have developed effective therapies and preventative vaccines. Severe COVID-19 infection is associated...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Canadian Cardiovascular Society. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886397/ https://www.ncbi.nlm.nih.gov/pubmed/36731604 http://dx.doi.org/10.1016/j.cjca.2023.01.022 |
_version_ | 1784880122014203904 |
---|---|
author | Crosier, Rebecca Kafil, Tahir S. Paterson, D. Ian |
author_facet | Crosier, Rebecca Kafil, Tahir S. Paterson, D. Ian |
author_sort | Crosier, Rebecca |
collection | PubMed |
description | After the first confirmed case in 2019, COVID-19 rapidly spread worldwide and overwhelmed the medical community. In the intervening time, we have learned about COVID-19’s clinical manifestations and have developed effective therapies and preventative vaccines. Severe COVID-19 infection is associated with many cardiovascular disorders in the acute phase, and patients recovered from illness can also manifest long-term sequelae, including long COVID syndrome. Furthermore, severe acute respiratory syndrome–related coronavirus-2 messenger RNA (mRNA) vaccination can trigger rare cases of myopericarditis. We have gained significant knowledge of the acute and long-term cardiovascular complications of COVID-19– and mRNA vaccine–associated myocarditis through clinical and investigative studies using cardiac imaging. In this review, we describe how cardiovascular imaging can be used to understand the cardiovascular complications and cardiac injury associated with acute COVID-19 infection, review the imaging findings in patients recovered from illness, and discuss the role and limitations of cardiac imaging in COVID-19 mRNA vaccine–associated myocarditis. |
format | Online Article Text |
id | pubmed-9886397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Canadian Cardiovascular Society. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98863972023-01-31 Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context Crosier, Rebecca Kafil, Tahir S. Paterson, D. Ian Can J Cardiol Review After the first confirmed case in 2019, COVID-19 rapidly spread worldwide and overwhelmed the medical community. In the intervening time, we have learned about COVID-19’s clinical manifestations and have developed effective therapies and preventative vaccines. Severe COVID-19 infection is associated with many cardiovascular disorders in the acute phase, and patients recovered from illness can also manifest long-term sequelae, including long COVID syndrome. Furthermore, severe acute respiratory syndrome–related coronavirus-2 messenger RNA (mRNA) vaccination can trigger rare cases of myopericarditis. We have gained significant knowledge of the acute and long-term cardiovascular complications of COVID-19– and mRNA vaccine–associated myocarditis through clinical and investigative studies using cardiac imaging. In this review, we describe how cardiovascular imaging can be used to understand the cardiovascular complications and cardiac injury associated with acute COVID-19 infection, review the imaging findings in patients recovered from illness, and discuss the role and limitations of cardiac imaging in COVID-19 mRNA vaccine–associated myocarditis. Canadian Cardiovascular Society. Published by Elsevier Inc. 2023-06 2023-01-31 /pmc/articles/PMC9886397/ /pubmed/36731604 http://dx.doi.org/10.1016/j.cjca.2023.01.022 Text en © 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Crosier, Rebecca Kafil, Tahir S. Paterson, D. Ian Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context |
title | Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context |
title_full | Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context |
title_fullStr | Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context |
title_full_unstemmed | Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context |
title_short | Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context |
title_sort | imaging for cardiovascular complications of covid-19: cardiac manifestations in context |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886397/ https://www.ncbi.nlm.nih.gov/pubmed/36731604 http://dx.doi.org/10.1016/j.cjca.2023.01.022 |
work_keys_str_mv | AT crosierrebecca imagingforcardiovascularcomplicationsofcovid19cardiacmanifestationsincontext AT kafiltahirs imagingforcardiovascularcomplicationsofcovid19cardiacmanifestationsincontext AT patersondian imagingforcardiovascularcomplicationsofcovid19cardiacmanifestationsincontext |